Actrapid is a fast-acting human insulin and may be used in combination with intermediate or long-acting insulin medicinal products. 1 vial contains 10 ml equivalent to 1,000 international units. 1 ml solution contains 100 international units insulin human* (equivalent to 3.5 mg). Human insulin is produced in Saccharomyces cerevisiae by recombinant DNA technology. Excipient with known effect: Actrapid contains less than 1 mmol sodium (23 mg) per dose, i.e. Actrapid is essentially 'sodium-free'. The potency of human insulin is expressed in international units. Actrapid dosing is individual and determined in accordance with the needs of the patient. It can be used alone or in combination with intermediate-acting or long-acting insulin before a meal or a snack. The individual insulin requirement is usually between 0.3 and 1.0 international unit/kg/day. Adjustment of dose may be necessary if patients undertake increased physical activity, change their usual diet or during concomitant illness.
Actrapid is a fast-acting human insulin and may be used in combination with intermediate or long-acting insulin medicinal products. 1 vial contains 10 ml equivalent to 1,000 international units. 1 ml solution contains 100 international units insulin human* (equivalent to 3.5 mg). Human insulin is produced in Saccharomyces cerevisiae by recombinant DNA technology. Excipient with known effect: Actrapid contains less than 1 mmol sodium (23 mg) per dose, i.e. Actrapid is essentially 'sodium-free'. The potency of human insulin is expressed in international units. Actrapid dosing is individual and determined in accordance with the needs of the patient. It can be used alone or in combination with intermediate-acting or long-acting insulin before a meal or a snack. The individual insulin requirement is usually between 0.3 and 1.0 international unit/kg/day. Adjustment of dose may be necessary if patients undertake increased physical activity, change their usual diet or during concomitant illness.